Diversified Healthcare Trust (DHC)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $1.75B
Last updated: Nov 17, 2026 at 11:04 AM ET
Diversified Healthcare Trust (DHC) Earnings: Report Dates and Results
FFO per share for Diversified Healthcare Trust (DHC) was $0.52 for 2025. In the quarter ended Sep 30, 2026, Diversified Healthcare Trust reported EPS of $0.13, below the $0.15 estimate. It beat the EPS estimate in 7 of the last 8 quarters. Diversified Healthcare Trust is expected to report earnings on Feb 22, 2027.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DHC has an expected report date of Feb 22, 2027.
DHC Earnings Call
The latest DHC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, DHC beat 19, missed 19 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $367.67M, down 5.4% from $388.71M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.13 | $0.15 | N/A | -13.33% | Miss | N/A | 1 | 1 up, 0 down | Nov 2, 2026 | $367.67M |
| Jun 30, 2026 | $0.16 | $0.14 | N/A | +14.29% | Beat | N/A | 2 | 1 up, 0 down | Aug 3, 2026 | $365.39M |
| Mar 31, 2026 | -$0.13 | -$0.16 | -$0.17 - -$0.15 | +18.75% | Beat | N/A | 3 | 0 up, 0 down | May 4, 2026 | $366.47M |
| Dec 31, 2025 | -$0.06 | -$0.18 | -$0.18 - -$0.18 | +65.06% | Beat | N/A | 1 | 1 up, 0 down | Feb 23, 2026 | $379.57M |
| Sep 30, 2025 | -$0.22 | -$0.23 | -$0.23 - -$0.23 | +4.35% | Beat | N/A | 1 | 0 up, 1 down | Nov 3, 2025 | $388.71M |
| Jun 30, 2025 | -$0.20 | -$0.23 | -$0.23 - -$0.23 | +13.04% | Beat | N/A | 1 | 1 up, 0 down | Aug 4, 2025 | $382.71M |
| Mar 31, 2025 | -$0.24 | -$0.28 | -$0.28 - -$0.28 | +14.29% | Beat | N/A | 1 | 0 up, 0 down | May 5, 2025 | $386.86M |
| Dec 31, 2024 | -$0.27 | -$0.29 | -$0.29 - -$0.29 | +6.55% | Beat | N/A | 1 | 0 up, 1 down | Feb 25, 2025 | $379.62M |
| Sep 30, 2024 | -$0.41 | -$0.26 | N/A | -58.38% | Miss | N/A | N/A | 0 up, 0 down | Nov 4, 2024 | $373.64M |
| Jun 30, 2024 | -$0.32 | -$0.28 | -$0.28 - -$0.28 | -14.29% | Miss | N/A | 1 | 0 up, 0 down | Aug 1, 2024 | $371.39M |
| Mar 31, 2024 | -$0.28 | -$0.28 | -$0.28 - -$0.28 | 0.00% | In line | N/A | 1 | 0 up, 0 down | May 6, 2024 | $370.78M |
| Dec 31, 2023 | -$0.43 | -$0.25 | -$0.25 - -$0.25 | -72.00% | Miss | N/A | 1 | 0 up, 0 down | Feb 26, 2024 | $361.54M |
| Sep 30, 2023 | -$0.28 | -$0.20 | N/A | -40.00% | Miss | N/A | N/A | 0 up, 0 down | Nov 1, 2023 | $356.52M |
| Jun 30, 2023 | -$0.30 | -$0.22 | N/A | -36.36% | Miss | N/A | 1 | 0 up, 0 down | Aug 1, 2023 | $346.22M |
| Mar 31, 2023 | -$0.22 | -$0.23 | -$0.23 - -$0.23 | +4.35% | Beat | -121.6% | 2 | 0 up, 0 down | May 8, 2023 | $346.03M |
| Dec 31, 2022 | -$0.25 | -$0.28 | -$0.28 - -$0.24 | +10.71% | Beat | N/A | 2 | 0 up, 0 down | Mar 1, 2023 | $336.88M |
| Sep 30, 2022 | -$0.31 | -$0.23 | N/A | -34.78% | Miss | N/A | 2 | 0 up, 0 down | Nov 2, 2022 | $322.92M |
| Jun 30, 2022 | -$0.33 | -$0.29 | N/A | -13.79% | Miss | N/A | N/A | 0 up, 0 down | Aug 3, 2022 | $313.03M |
| Mar 31, 2022 | $1.02 | $1.04 | N/A | -1.92% | Miss | N/A | 2 | 0 up, 0 down | May 3, 2022 | $310.73M |
| Dec 31, 2021 | -$0.40 | -$0.24 | -$0.24 - -$0.24 | -66.67% | Miss | N/A | 1 | N/A | Feb 23, 2022 | $336.73M |
| Sep 30, 2021 | -$0.30 | -$0.24 | -$0.24 - -$0.22 | -25.00% | Miss | N/A | 2 | N/A | Nov 3, 2021 | $337.42M |
| Jun 30, 2021 | -$0.22 | -$0.23 | N/A | +4.35% | Beat | -1200.0% | 3 | N/A | Aug 4, 2021 | $346.34M |
| Mar 31, 2021 | -$0.28 | -$0.23 | -$0.25 - -$0.20 | -21.74% | Miss | -800.0% | 3 | N/A | May 5, 2021 | $362.72M |
| Dec 31, 2020 | -$0.07 | -$0.22 | -$0.24 - -$0.20 | +68.18% | Beat | -333.3% | 3 | N/A | Feb 24, 2021 | $384.91M |
| Sep 30, 2020 | -$0.21 | -$0.12 | N/A | -75.00% | Miss | -2200.0% | 4 | N/A | Nov 5, 2020 | $394.34M |
| Jun 30, 2020 | $0.02 | -$0.16 | -$0.23 - $0.01 | +112.50% | Beat | -60.0% | 4 | N/A | Aug 6, 2020 | $410.31M |
| Mar 31, 2020 | $0.04 | -$0.08 | -$0.28 - $0.06 | +150.00% | Beat | -55.6% | 3 | N/A | May 7, 2020 | $442.47M |
| Dec 31, 2019 | $0.03 | $0.03 | $0.02 - $0.05 | 0.00% | In line | N/A | 3 | N/A | Mar 2, 2020 | $256.04M |
| Sep 30, 2019 | $0.01 | $0.02 | N/A | -50.00% | Miss | -92.9% | N/A | N/A | Nov 7, 2019 | $255.83M |
| Jun 30, 2019 | $0.05 | $0.07 | N/A | -28.57% | Miss | -68.8% | N/A | N/A | Aug 8, 2019 | $262.00M |
| Mar 31, 2019 | $0.09 | $0.10 | N/A | -10.00% | Miss | -89.8% | N/A | N/A | May 9, 2019 | $266.29M |
| Dec 31, 2018 | -$0.50 | $0.16 | N/A | -412.50% | Miss | -327.3% | N/A | N/A | Mar 1, 2019 | $285.22M |
| Sep 30, 2018 | $0.14 | $0.12 | N/A | +16.67% | Beat | -22.2% | N/A | N/A | Nov 6, 2018 | $278.97M |
| Jun 30, 2018 | $0.16 | $0.14 | N/A | +14.29% | Beat | +14.3% | N/A | N/A | Aug 7, 2018 | $277.20M |
| Mar 31, 2018 | $0.88 | $0.16 | N/A | +450.00% | Beat | +528.6% | N/A | N/A | May 9, 2018 | $275.77M |
| Dec 31, 2017 | $0.22 | $0.16 | N/A | +37.50% | Beat | +22.2% | N/A | N/A | Feb 27, 2018 | $278.48M |
| Sep 30, 2017 | $0.18 | $0.16 | N/A | +12.50% | Beat | +28.6% | N/A | N/A | Nov 9, 2017 | $266.67M |
| Jun 30, 2017 | $0.14 | $0.15 | N/A | -6.67% | Miss | -17.6% | N/A | N/A | Aug 3, 2017 | $265.01M |
| Mar 31, 2017 | $0.14 | $0.15 | N/A | -6.67% | Miss | -12.5% | N/A | N/A | May 5, 2017 | $264.56M |
| Dec 31, 2016 | $0.18 | $0.16 | N/A | +12.50% | Beat | -10.0% | N/A | N/A | Feb 27, 2017 | $274.30M |
Annual FFO
FFO per share was $0.52 for 2025, up 92.6% from $0.27 in 2024. It was $1.84 for 2016, the oldest of the 10 years shown.
| Fiscal year | FFO per share | Change |
|---|---|---|
| 2025 | $0.52 | +92.6% |
| 2024 | $0.27 | N/A |
| 2023 | -$0.16 | N/A |
| 2022 | -$0.03 | N/A |
| 2021 | $0.67 | -48.9% |
| 2020 | $1.31 | -17.6% |
| 2019 | $1.59 | +0.6% |
| 2018 | $1.58 | -16.0% |
| 2017 | $1.88 | +2.2% |
| 2016 | $1.84 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.72, after -$1.28 the year before. It was $0.65 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.72 | N/A |
| Dec 31, 2024 | -$1.28 | N/A |
| Dec 31, 2023 | -$1.23 | -1046.2% |
| Dec 31, 2022 | $0.13 | N/A |
| Dec 31, 2021 | -$1.20 | N/A |
| Dec 31, 2020 | -$0.22 | -222.2% |
| Dec 31, 2019 | $0.18 | -73.5% |
| Dec 31, 2018 | $0.68 | N/A |
| Dec 31, 2017 | $0.68 | N/A |
| Dec 31, 2016 | $0.65 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,800 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 3,795 | 6 | |
| 2026Q2 | Jun 30, 2026 | 3,464 | 7 | |
| 2026Q1 | Mar 31, 2026 | 3,674 | 7 | |
| 2025Q4 | Dec 31, 2025 | 4,166 | 8 | |
| 2025Q3 | Sep 30, 2025 | 3,410 | 6 | |
| 2025Q2 | Jun 30, 2025 | 3,467 | 7 | |
| 2025Q1 | Mar 31, 2025 | 3,282 | 7 | |
| 2024Q4 | Dec 31, 2024 | 3,499 | 7 |
2026Q3 Earnings Call
Opening remarks
Matt Murphy Manager of Investor Relations Good morning. Joining me on today's call are Christopher J. Bilotto, President and Chief Executive Officer, and Matthew C. Brown, Chief Financial Officer and Treasurer. Today's call includes a presentation by management followed by a question-and-answer session with sell-side analysts. Please note that the recording and retransmission of today's conference call are strictly prohibited without the prior written consent of the company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 2002 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations as of today, Tuesday, November 3, 2026. The company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call, other than through filings with the Securities and Exchange Commission, or SEC. Actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. In addition, this call may contain non-GAAP numbers, including normalized funds from operations, or normalized FFO; net operating income, or NOI; cash-basis net operating income, or cash-basis NOI; and Adjusted EBITDAre. A reconciliation of these non-GAAP measures to net income is available in our financial results package, which can be found on our website at www.dhcreit.com. Beginning this quarter, our calculations of normalized FFO and Adjusted EBITDAre include estimated incentive management fees accrued under GAAP, and prior periods have been recast to conform to this presentation. Finally, we will be providing guidance on this call, including NOI. We are not providing a reconciliation of these non-GAAP measures as part of our guidance because certain information required for such a reconciliation is not available without unreasonable effort or at all, such as gains and losses or impairment charges related to the disposition of real estate. With that, I would now like to turn the call over to Christopher.
Christopher J. Bilotto President and Chief Executive Officer Thank you, Matthew. Good morning, everyone. Thank you for joining our call today. Our third-quarter results reflect continued execution on the strategy we have laid out for the year. That strategy shows up across stronger operating results in our SHOP portfolio, active optimization of how we own and operate individual assets, and a steadily improving financial profile. Following the market close yesterday, DHC reported normalized FFO of $30.7 million, or $0.13 per share, and Adjusted EBITDAre of $73.4 million, an increase of 28.4% year over year. Same-property cash-basis NOI increased 25.6% to $77.9 million, and consolidated NOI increased 27.5% to $80.8 million. Before going further, I want to note a change in our presentation.
Frequently Asked Questions About DHC
When is Diversified Healthcare Trust's next earnings date?
Diversified Healthcare Trust's next earnings report is expected for Feb 22, 2027.
Did DHC beat earnings estimates last quarter?
No. Diversified Healthcare Trust reported EPS of $0.13 for the quarter ended Sep 30, 2026, below the $0.15 estimate by 13.33%.
What EPS do analysts expect from DHC next quarter?
The consensus EPS estimate for Diversified Healthcare Trust for the quarter ending Dec 31, 2026 is -$0.14 from 4 analysts.
How often does DHC beat earnings estimates?
Diversified Healthcare Trust beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +15.37%.
DHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors